1 Philips V60 Plus ventilator software upgrade is provided in the US under an FDA emergency use policya, which authorizes its use for the duration of the COVID-19 public health emergency declaration, after which the software upgrade may no longer be used. This device is not FDA cleared or approved.
a Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, issued March 2020
Note:
· The V60 Plus promotion commences at 9:00am EST, August 1, 2020 and ends at 11:59pm EST, December 31, 2020.
· This promotion is available to direct customers and distributors.
Relevant part numbers:
AC611: S, AC611 HFNC, 22MM (M), INT, 20 PK, 989805656851 / 1134196; M, AC611 HFNC, 22MM (M), INT, 20 PK, 989805656861 / 1134197; L, AC611 HFNC, 22MM (M), INT, 20 PK, 989805656871 / 1134198; S, AC611 HFNC, FEP Connect, 20 PK, 989805656791 / 1134190; M, AC611 HFNC, FEP Connect, 20 PK, 989805656801 / 1134191, L, AC611 HFNC, FEP Connect, 20 PK, 989805656811 / 1134192
V60 Plus Software Upgrade: HFT OPTION, FIELD UPGRADE, 989805657401/1136155
2 Note:
· The Trilogy EV300 promotion commences at 9:00am EST, August 1, 2020 and ends at 11:59pm EST, December 31, 2020.
· This promotion is available to direct customers and distributors.
3 The Philips Respironics E30 Ventilator is provided globally for use under local emergency use authorizations, such as the FDA Emergency Use Authorization for ventilators, Health Canada Interim Order for use in relation to COVID-19, and waiver of CE marking, which authorize its use for the duration of the COVID-19 public health emergency, unless terminated or revoked (after which the products may no longer be used). This device is not FDA cleared or approved.
Relevant part numbers: DSX9999H11, Philips Respironics E30 (domestic); INX9999H19, Philips Respironics E30 (international)
4 Please note: not all products are available in all geographies. Please check with your Philips representative or call us at 074-7334409 for complete portfolio availability.